ResearchIn-Press PreviewImmunology
Open Access |
10.1172/jci.insight.193054
1HSS Research Institute, Hospital for Special Surgery, New York, United States of America
2Computational and Systems Biology Program, Memorial Sloan Kettering Cancer Center, New York, United States of America
3Department of Pathology and Laboratory Medicine, Hospital for Special Surgery, New York, United States of America
4Division of Rheumatology, Department of Medicine, Hospital for Special Surgery, New York, United States of America
5Weill Cornell Medical College, New York, United States of America
Find articles by Romoff, M. in: PubMed | Google Scholar
1HSS Research Institute, Hospital for Special Surgery, New York, United States of America
2Computational and Systems Biology Program, Memorial Sloan Kettering Cancer Center, New York, United States of America
3Department of Pathology and Laboratory Medicine, Hospital for Special Surgery, New York, United States of America
4Division of Rheumatology, Department of Medicine, Hospital for Special Surgery, New York, United States of America
5Weill Cornell Medical College, New York, United States of America
Find articles by Periyakoil, P. in: PubMed | Google Scholar
1HSS Research Institute, Hospital for Special Surgery, New York, United States of America
2Computational and Systems Biology Program, Memorial Sloan Kettering Cancer Center, New York, United States of America
3Department of Pathology and Laboratory Medicine, Hospital for Special Surgery, New York, United States of America
4Division of Rheumatology, Department of Medicine, Hospital for Special Surgery, New York, United States of America
5Weill Cornell Medical College, New York, United States of America
Find articles by DiCarlo, E. in: PubMed | Google Scholar
1HSS Research Institute, Hospital for Special Surgery, New York, United States of America
2Computational and Systems Biology Program, Memorial Sloan Kettering Cancer Center, New York, United States of America
3Department of Pathology and Laboratory Medicine, Hospital for Special Surgery, New York, United States of America
4Division of Rheumatology, Department of Medicine, Hospital for Special Surgery, New York, United States of America
5Weill Cornell Medical College, New York, United States of America
Find articles by Ramirez, D. in: PubMed | Google Scholar
1HSS Research Institute, Hospital for Special Surgery, New York, United States of America
2Computational and Systems Biology Program, Memorial Sloan Kettering Cancer Center, New York, United States of America
3Department of Pathology and Laboratory Medicine, Hospital for Special Surgery, New York, United States of America
4Division of Rheumatology, Department of Medicine, Hospital for Special Surgery, New York, United States of America
5Weill Cornell Medical College, New York, United States of America
Find articles by Goodman, S. in: PubMed | Google Scholar
1HSS Research Institute, Hospital for Special Surgery, New York, United States of America
2Computational and Systems Biology Program, Memorial Sloan Kettering Cancer Center, New York, United States of America
3Department of Pathology and Laboratory Medicine, Hospital for Special Surgery, New York, United States of America
4Division of Rheumatology, Department of Medicine, Hospital for Special Surgery, New York, United States of America
5Weill Cornell Medical College, New York, United States of America
Find articles by
Leslie, C.
in:
PubMed
|
Google Scholar
|
1HSS Research Institute, Hospital for Special Surgery, New York, United States of America
2Computational and Systems Biology Program, Memorial Sloan Kettering Cancer Center, New York, United States of America
3Department of Pathology and Laboratory Medicine, Hospital for Special Surgery, New York, United States of America
4Division of Rheumatology, Department of Medicine, Hospital for Special Surgery, New York, United States of America
5Weill Cornell Medical College, New York, United States of America
Find articles by Rudensky, A. in: PubMed | Google Scholar
1HSS Research Institute, Hospital for Special Surgery, New York, United States of America
2Computational and Systems Biology Program, Memorial Sloan Kettering Cancer Center, New York, United States of America
3Department of Pathology and Laboratory Medicine, Hospital for Special Surgery, New York, United States of America
4Division of Rheumatology, Department of Medicine, Hospital for Special Surgery, New York, United States of America
5Weill Cornell Medical College, New York, United States of America
Find articles by Donlin, L. in: PubMed | Google Scholar
1HSS Research Institute, Hospital for Special Surgery, New York, United States of America
2Computational and Systems Biology Program, Memorial Sloan Kettering Cancer Center, New York, United States of America
3Department of Pathology and Laboratory Medicine, Hospital for Special Surgery, New York, United States of America
4Division of Rheumatology, Department of Medicine, Hospital for Special Surgery, New York, United States of America
5Weill Cornell Medical College, New York, United States of America
Find articles by Smith, M. in: PubMed | Google Scholar
Published October 7, 2025 - More info
In the rheumatoid arthritis (RA) synovium, resident fibroblast-like synoviocytes (FLS) express MHC class II molecules (HLA-D) but lack the co-stimulatory signals typically required for T cell activation. Here, we demonstrate that antigen presentation by FLS induces a distinct T cell activation state characterized by high CD69, yet reduced CD25 and HLA-DR expression, suppressed proliferation, and decreased effector cytokine production compared to professional antigen presenting cells (APCs), such as macrophages. FLS were also capable of suppressing macrophage-induced T cell activation, underscoring their dominant immunomodulatory role in the synovial microenvironment. Mechanistically, we identify indoleamine 2,3-dioxygenase (IDO1)-mediated tryptophan depletion as the primary driver of FLS-induced T cell hypo-responsiveness. Spatial transcriptomics revealed colocalization of IDO1 and CD69 within ectopic lymphoid structures in RA synovium, further supporting the in vivo relevance of this pathway. These findings provide the groundwork for positioning FLS as critical T cell regulators in RA and highlight the importance of preserving their immunosuppressive properties when therapeutically targeting pathogenic FLS functions.